This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Elliott, P. J. Articles by Bartus, R. T. Search for Related Content PubMed PubMed Citation Articles by Elliott, P. J. Articles by Bartus, R. T.

Intravenous RMP-7 Selectively Increases Uptake of Carboplatin into Rat Brain Tumors

Alkermes, Inc., Cambridge, Massachusetts 02139 [P. J. E., N. J. H., R. L. D., D. G. B., R. T. B.], and Department of Pharmacology and Experimental Therapeutics, Tufts University, Boston, Massachusetts 02111 [R. T. B.]

Rats implanted with RG-2 gliomas were administered i.v. RMP-7 and [¹⁴C]carboplatin. Changes in the permeability of the blood-brain barrier to carboplatin were determined using quantitative autoradiography. i.v. infusions of RMP-7 induced an increase in the permeability of the vascular barrier within the tumor to carboplatin. Additionally, permeability of brain tissue proximal to, but clearly outside the tumor mass, was also increased. Progressively less uptake of [¹⁴C]carboplatin was observed as distance from the tumor border increased. The increases in permeability induced by RMP-7 occurred in a dose-related fashion. No increase in carboplatin level was observed in several nonbrain tissues, including sciatic nerve, retina, heart, lung, liver, kidney, and spleen. Finally, the permeabilizing effects of RMP-7 were shown to occur independent of histaminergic or hypotensive mechanisms. These data provide additional insight into the permeabilizing effects and mechanism of RMP-7 and offer additional support for the therapeutic utility of this novel compound as an adjunctive treatment for human gliomas.

¹ To whom requests for reprints should be addressed, at Alkermes, Inc., 64 Sidney Street, Cambridge, MA 02139. Phone: (617) 494-0171; Fax: (617) 494-9263. e-Mail: rtbartus@alkermes.com.

Received 12/28/95. Accepted 6/28/96.

This article has been cited by other articles:

				M. D. Prados, S. C. Schold Jr., H. A. Fine, K. Jaeckle, F. Hochberg, L. Mechtler, M. R. Fetell, S. Phuphanich, L. Feun, T. J. Janus, et al. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma Neuro-oncol, April 1, 2003; 5(2): 96 - 103. [Abstract] [PDF]

				D. J. Bidanset, L. Placidi, R. Rybak, J. Palmer, J.-P. Sommadossi, and E. R. Kern Intravenous Infusion of Cereport Increases Uptake and Efficacy of Acyclovir in Herpes Simplex Virus-Infected Rat Brains Antimicrob. Agents Chemother., August 1, 2001; 45(8): 2316 - 2323. [Abstract] [Full Text] [PDF]

				D. F. Emerich, P. Snodgrass, R. L. Dean, D. Lafreniere, M. Agostino, T. Wiens, H. Xiong, B. Hasler, J. Marsh, M. Pink, et al. Bradykinin Modulation of Tumor Vasculature: I. Activation of B2 Receptors Increases Delivery of Chemotherapeutic Agents into Solid Peripheral Tumors, Enhancing Their Efficacy J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 623 - 631. [Abstract] [Full Text]

				D. F. Emerich, R. L. Dean, P. Snodgrass, D. Lafreniere, M. Agostino, T. Wiens, H. Xiong, B. Hasler, J. Marsh, M. Pink, et al. Bradykinin Modulation of Tumor Vasculature: II. Activation of Nitric Oxide and Phospholipase A2/Prostaglandin Signaling Pathways Synergistically Modifies Vascular Physiology and Morphology to Enhance Delivery of Chemotherapeutic Agents to Tumors J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 632 - 641. [Abstract] [Full Text]

				R. T. Bartus, P. Snodgrass, J. Marsh, M. Agostino, A. Perkins, and D. F. Emerich Intravenous Cereport (RMP-7) Modifies Topographic Uptake Profile of Carboplatin within Rat Glioma and Brain surrounding Tumor, Elevates Platinum Levels, and Enhances Survival J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 903 - 911. [Abstract] [Full Text]

				R. L. Dean, D. F. Emerich, B. P. Hasler, and R. T. Bartus Cereport(R) (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone Neuro-oncol, October 1, 1999; 1(4): 268 - 274. [Abstract] [PDF]